Introducing ThymoTropin: A Groundbreaking OTC Solution for Muscle Health by Veos Pharmaceuticals

MADRID, Spain, 21st Jan 2025, – Veos Pharmaceuticals, a leading innovator with a portfolio of nearly 40 products across the EU, US, and Canada, today announced the launch of ThymoTropin, a revolutionary over-the-counter (OTC) solution for muscle growth, repair, and preservation. ThymoTropin, powered by clinically validated thymol and carvacrol, is the first product of its kind targeting myostatin regulation, a crucial mechanism for maintaining muscle mass and performance.

As part of Veos Pharma’s commitment to delivering science-backed innovations, ThymoTropin addresses the unique needs of individuals experiencing muscle loss due to aging, chronic disease, or weight management regimens, including GLP-1 treatments and calorie-restricted diets.

Filling a Critical Gap in Muscle Health:

More than 50% of individuals undergoing weight loss or battling chronic illnesses face muscle loss, impacting their mobility, strength, and overall health. ThymoTropin is formulated to counteract this decline by preserving and enhancing muscle mass through its innovative dual-action mechanism:

• Clinically proven myostatin regulation for targeted muscle preservation.
• Support for lean muscle growth and endurance, validated through preclinical and clinical studies.

“At Veos Pharmaceuticals, we are committed to addressing critical health gaps with effective, science-driven solutions,” said Dr. Bassam Damaj, Executive Chairman of Veos Pharma. “ThymoTropin is a game-changer in muscle health, offering proven benefits for individuals managing muscle loss while aligning with modern health goals, including weight loss and ageing-related care.”

Clinically Backed, Patented Innovation:

ThymoTropin is supported by a robust patent portfolio, including:

• US Patent No. 11,135,178: Enhancing Muscle Growth via Monoterpenes
• CA Patent No. 2,964,239: Applications of Monoterpenes in Muscle Health
• EP Patent No. 3191086: Monoterpene Formulations for Muscle Enhancement
• PT Patent No. 3191086: Monoterpenes for Myostatin Regulation

Clinical results demonstrate up to a 50% increase in muscle mass and a 37% improvement in endurance. ThymoTropin’s unique focus on myostatin regulation differentiates it from traditional protein supplements, making it a superior solution for muscle health.

Targeted Nutrition for Growing Market Needs:

The global market for muscle health and repair products continues to grow, driven by increasing demand from aging populations, oncology patients, and fitness-conscious individuals. ThymoTropin directly addresses these needs by providing:

• Muscle preservation during weight loss
• Enhanced recovery and repair
• Support for aging-related muscle decline

In a competitive landscape dominated by protein supplements like Abbott’s Protality and Nestle Boost, ThymoTropin stands out with its clinically validated myostatin regulation mechanism. Unlike traditional products, ThymoTropin offers targeted efficacy without unnecessary calories or sugars, making it an ideal solution for modern health-conscious consumers.

Growing Market Opportunity and Competitive Landscape:

The global muscle health and nutritional support market are projected to exceed $15 billion by 2025, driven by increasing demand from ageing populations, oncology-supportive care, and weight management solutions. Competitor products such as Abbott’s Protality and Nestle Boost have collectively generated impressive sales, with:

• Protality generates an estimated annual revenue of $300 million and a 15% market share.
• Nestle Boost® generates an estimated $500 million annually with a 25% market share.
• Traditional whey protein supplements lead with over $8 billion in annual revenue and a dominant 60% market share.

While competitor products focus on general protein supplementation, ThymoTropin sets itself apart by targeting myostatin regulation, offering a precise and effective solution for muscle growth and preservation without unnecessary calories or sugars.

Available as an Ingredient for B2B Applications:

ThymoTropin is offered as a premium ingredient for business-to-business (B2B) formulations. This enables manufacturers in the health, nutrition, and functional food sectors to incorporate ThymoTropin’s proven myostatin-targeting benefits into their products, meeting growing consumer demand for advanced muscle health solutions. Veos Pharma partners with businesses to provide customized solutions and ensure seamless integration into existing product lines.

About Veos Pharmaceuticals:

Headquartered in Madrid, Spain, Veos Pharmaceuticals is a global leader in health innovation with a portfolio of nearly 40 products across the EU, US, and Canada. The company specializes in OTC solutions, biostimulants, and advanced nutritional products aimed at improving quality of life. Veos Pharma’s flagship products include Ocufresh®, BioPropello, OleoSorb, VEOX-Preserv, and ThymoTropin.

For more information, contact:

Dr. Bassam Damaj
Executive Chairman
Veos Pharmaceuticals, SL
Email: info@veospharma.com
Website: www.veospharma.com

Protality is a trademark of Abbott Laboratories. Boost® is a trademark of Nestlé

References:

www.grandviewresearch.com/industry-analysis/sports-supplement-market

Forward-Looking Statements: This press release may contain forward-looking statements that involve risks and uncertainties. Veos Pharmaceuticals assumes no obligation to update or revise these statements after the date of publication.

Media Contact

Organization: Veos Pharmaceuticals

Contact
Person: Dr. Bassam Damaj

Website:

https://www.veospharma.com/

Email:

info@veospharma.com

Contact Number: 34911925649

City: MADRID

Country:Spain

The post Veos Pharmaceuticals Unveils ThymoTropin to Support Muscle Health and Preservation During Weight Loss and Aging Journeys appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.

On January 16, 2025, Smart City Development Holdings (HK. 8268) announced that the company has signed a strategic cooperation memorandum with OAM Global Limited (OAM Global) to promote the development and implementation of AI computing labs and AI assistants (AI Agent). According to the memorandum, the company plans to utilize OAM Global’s professional knowledge in the field of machine learning and algorithmic trading to further develop smart city infrastructure. Through this cooperation, the company will introduce AI computing labs and AI assistants to enhance its smart city service capabilities to meet the future demand for artificial intelligence technology in smart cities.

Under the cooperation framework, the company can provide space for the construction of AI computing labs. OAM Global is responsible for building and operating these labs, providing the necessary computing resources for the company, and promoting the application and development of smart technologies in various urban service areas. The construction of AI computing labs aims to provide efficient computational support for the infrastructure of smart cities, thereby improving the overall efficiency of the system.

OAM Global will develop a solution called OAM AI Assistant (AI Agent), which aims to provide convenient life assistance services for the company’s customers. The AI assistant system will be integrated into the company’s service system to optimize customer experience.

Mr. Raymond, Market Development Director of OAM Global, said: “The cooperation with Smart City Development Holdings will be a significant milestone, not only bringing technological breakthroughs but also injecting new vitality into the entire Asia-Pacific market.”

The board of directors of Smart City Development Holdings believes that signing the strategic cooperation memorandum aligns with the company’s development strategy and the overall interests of the company and its shareholders. The memorandum allows both parties to utilize their respective strengths, resources, and professional knowledge to establish a stable and mutually beneficial strategic relationship for the development and construction of smart cities, as well as expanding the company’s revenue sources, bringing higher returns to shareholders.

About OAM Global

OAM Global is an international asset management company specializing in providing cutting-edge algorithmic trading solutions. The company advocates for the synergy of technology, community, and capital value. OAM Global is committed to delivering high-quality investment returns through advanced technology and innovative financial products. By continuously exploring new financial technologies, OAM Global aims to drive industry advancement and create greater value for its clients.

About Smart City Development Holdings

Smart City Development Holdings (HK. 8268) is a Hong Kong-listed company focused on the development of smart city infrastructure. The company leverages artificial intelligence and machine learning technologies to enhance the efficiency and quality of urban services. Through strategic partnerships with industry leaders, Smart City Development Holdings continuously drives innovation and development in smart cities, providing residents with smarter and more convenient living experiences.

Media Contact

Company Name: OAM Global Limited 

Region: Hong Kong 

Email: contact@oam-global.com 

Contact Person: Andrew Kang 

Website: https://www.oam-global.com

Source: https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-01-16/doc-inefenpt6662234.shtml?cref=cj

FX273, a leading UK-based trading firm, has taken the financial world by storm with record-breaking growth in the stocks and commodities markets. Known for its innovative platform and investor-focused approach, FX273 continues to attract traders seeking reliable tools and opportunities in a dynamic market environment.

This milestone cements FX273’s reputation as the go-to firm for stocks and commodities trading, offering unmatched transparency, efficiency, and performance.

Timely Announcements: What Sets FX273 Apart in 2025?

1. Advanced Trading Algorithms for Stocks and Commodities

FX273 recently launched its proprietary AI-powered trading tools, optimized for analyzing stock and commodity markets with unparalleled precision. These tools empower traders with real-time insights and predictive analytics, making it easier to identify lucrative opportunities.

The company’s algorithms have delivered consistent results, helping clients navigate market volatility with confidence.

2. Zero Fees for First-Time Traders

To celebrate its exceptional growth, FX273 is offering zero commission on all trades for new clients during their first 90 days. This initiative aims to make professional trading more accessible to individuals who are exploring stocks and commodities for the first time.

3. Expanded Educational Programs

Recognizing that education is key to successful trading, FX273 has expanded its investor education platform. New features include:

• Interactive courses on stock and commodity trading strategies.
• Weekly market analysis reports from industry experts.
• One-on-one mentorship for premium users.

The FX273 Advantage: Why Investors Choose Us

Streamlined User Experience

FX273’s state-of-the-art trading platform is built for simplicity and efficiency, ensuring that traders—from beginners to professionals—can execute trades seamlessly.

Wide Market Access

Investors gain access to a diverse range of stocks and commodities, enabling them to build diversified portfolios that mitigate risks and enhance returns.

24/7 Client Support

FX273 prides itself on its responsive customer support team, available around the clock to assist traders with their queries and ensure uninterrupted trading experiences.

Client Success Stories

Here’s what FX273 clients are saying about their experiences:

• “FX273’s trading platform is a game-changer. I’ve seen incredible results in my commodities portfolio thanks to their AI-powered tools.” – James Carter, London
• “The zero-commission offer made it so easy to get started with stock trading. I’m already seeing great results!” – Emma Roberts, Manchester
• “I’ve traded on multiple platforms, but FX273’s educational resources and expert guidance set them apart. Highly recommend!” – Olivia Turner, Birmingham

Key Differentiators of FX273

1. Transparency and Integrity: No hidden fees or complicated terms.
2. Data-Driven Decisions: Advanced analytics tools for smarter trading.
3. Commitment to Security: Cutting-edge technology to safeguard client funds and personal data.

With its robust platform and unwavering dedication to client success, FX273 is setting new benchmarks in the trading industry.

Plans for 2025: FX273’s Vision

As FX273 continues to lead the trading space, the company has ambitious plans for the year ahead:

• Global Expansion: Introducing services to select European and Asian markets.
• Mobile Trading App: Launching a new mobile app with enhanced usability and offline trading capabilities.
• Sustainability Focus: Exploring opportunities in renewable energy commodities.

“FX273’s journey is just beginning. We’re dedicated to empowering investors with the tools and insights they need to succeed in an ever-changing market,” a company spokesperson stated.

Ready to elevate your trading experience? Join the thousands of UK investors who trust FX273 for their stock and commodity trades. Sign up today to take advantage of the zero-commission trading offer and gain access to industry-leading tools.

About FX273

FX273 is a UK-based trading firm specializing in stocks and commodities.